OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
41 hedge funds and large institutions have $16.9M invested in OncoMed Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$615K | |
| 2 | +$208K | |
| 3 | +$80.5K | |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$69K |
| 5 |
AP
Appleton Partners
Boston,
Massachusetts
|
+$69K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$120K | |
| 3 | -$74.8K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$64K |
| 5 |
Primecap Management
Pasadena,
California
|
-$57.1K |